148
Participants
Start Date
February 22, 2018
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
acetylsalicylic acid
Patients treated with acetylsalicylic acid 80 mg once daily for 5 years. Patients will be stratified according to the admission of adjuvant chemotherapy.
Placebo
Patients treated with placebo. Patients will be stratified according to the admission of adjuvant chemotherapy.
CHIREC, Brussels
Clinique Saint-Pierre, Ottignies-Louvain-la-Neuve
Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp
AZ Monica, Deurne
AZ Sint-Dimpna, Geel
Gasthuiszusters Ziekenhuizen (GZA), Antwerp
UZ Antwerpen, Edegem
AZ Rivierenland campus Rumst (Heilige Familie), Rumst
AZ Rivierenland campus Bornem (Sint Jozefkliniek), Bornem
AZ Klina, Brasschaat
RZ Heilig Hart, Leuven
Jessa Ziekenhuis, Hasselt
AZ Sint-Trudo, Sint-Truiden
CHR de la Citadelle, Liège
CHR Verviers, Verviers
CHU UCL Namur Site de Sainte-Elisabeth, Namur
Clinique Saint-Luc, Bouge
Grand Hôpital de Charleroi, Charleroi
CH de l'Ardenne, Libramont
CHU Ambroise Paré, Mons
CH de Mouscron, Mouscron
AZ Sint-Lucas, Bruges
AZ Groeninge, Kortrijk
OLV van Lourdes Ziekenhuis, Waregem
AZ Maria Middelares, Ghent
VITAZ (AZ Nikolaas), Sint-Niklaas
AZ Sint-Blasius, Dendermonde
AZ Glorieux, Ronse
AZ Alma, Eeklo
Kom Op Tegen Kanker
OTHER
Anticancerfund
UNKNOWN
University Hospital, Antwerp
OTHER